Jeff Marc Goldberg - Net Worth and Insider Trading
Jeff Marc Goldberg Net Worth
The estimated net worth of Jeff Marc Goldberg is at least $52,330 dollars as of 2025-04-27. Jeff Marc Goldberg is the COO of Akcea Therapeutics Inc and owns about 2,880 shares of Akcea Therapeutics Inc (AKCA) stock worth over $52,330. Details can be seen in Jeff Marc Goldberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeff Marc Goldberg has not made any transactions after 2019-04-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jeff Marc Goldberg
Jeff Marc Goldberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeff Marc Goldberg owns 2 companies in total, including Akcea Therapeutics Inc (AKCA) , and Spyre Therapeutics Inc (SYRE) .
Click here to see the complete history of Jeff Marc Goldberg’s form 4 insider trades.
Insider Ownership Summary of Jeff Marc Goldberg
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
AKCA | Akcea Therapeutics Inc | 2019-09-26 | Chief Operating Officer |
SYRE | Spyre Therapeutics Inc | 2022-11-29 | director & President and CEO |
Jeff Marc Goldberg Latest Holdings Summary
Jeff Marc Goldberg currently owns a total of 1 stock. Jeff Marc Goldberg owns 2,880 shares of Akcea Therapeutics Inc (AKCA) as of April 8, 2019, with a value of $52,330.
Latest Holdings of Jeff Marc Goldberg
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AKCA | Akcea Therapeutics Inc | 2019-04-08 | 2,880 | 18.17 | 52,330 |
Holding Weightings of Jeff Marc Goldberg
Jeff Marc Goldberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeff Marc Goldberg has made a total of 0 transactions in Akcea Therapeutics Inc (AKCA) over the past 5 years. The most-recent trade in Akcea Therapeutics Inc is the sale of 50,000 shares on April 8, 2019, which brought Jeff Marc Goldberg around $2 Million.
Insider Trading History of Jeff Marc Goldberg
- 1
Jeff Marc Goldberg Trading Performance
Jeff Marc Goldberg Ownership Network
Ownership Network List of Jeff Marc Goldberg
Ownership Network Relation of Jeff Marc Goldberg

Jeff Marc Goldberg Owned Company Details
What does Akcea Therapeutics Inc do?
Who are the key executives at Akcea Therapeutics Inc?
Jeff Marc Goldberg is the Chief Operating Officer of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include director & Chief Executive Officer Damien Mcdevitt , Chief Medical Officer William T. Andrews , and Chief Financial Officer Michael Dennis Price .
Akcea Therapeutics Inc (AKCA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akcea Therapeutics Inc Insider Transactions
Jeff Marc Goldberg Mailing Address
Above is the net worth, insider trading, and ownership report for Jeff Marc Goldberg. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeff Marc Goldberg's mailing address is: Cambridge Ma 02142.